Furthermore, we noted an increasing trend in the diagnostic efficacy of sarcopenia measurement for distinguishing stable or progressive disease over the one-to-three-month period following TARE.
← all excerpts
The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study.
1
—
—